Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

HKT-500-US12 In Adult Patients With OA Knee Pain

ClinicalTrials.gov ID: NCT00647231

Public ClinicalTrials.gov record NCT00647231. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 2:04 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Protocol HKT-500-US12: A Randomized, Multicenter, Double-Blind, Single Dose Study of the Analgesic Properties of HKT-500 and Placebo in Subjects With Pain Caused by Mild to Moderate Osteoarthritis of the Knee

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study is to characterize the analgesic properties of single dose study of HKT-500 in subjects with pain caused by mild to moderate OA of the knee

Study identification

NCT ID
NCT00647231
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
300 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
45 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 29, 2008
Primary completion
Jul 31, 2008
Completion
Jul 31, 2008
Last update posted
Jun 3, 2015

2008

United States locations

U.S. sites
29
U.S. states
19
U.S. cities
28
Facility City State ZIP Site status
Hisamitsu Investigator Site Birmingham Alabama 35209
Hisamitsu Investigator Site Phoenix Arizona 85013
Hisamitsu Investigator Site Little Rock Arkansas 72205
Hisamitsu Investigator Site Little Rock Arkansas 72211
Hisamitsu Investigator Site Burbank California 91505
Hisamitsu Investigator Site Escondido California 92025
Hisamitsu Investigator Site Northridge California 91325
Hisamitsu Investigator Site Colorado Springs Colorado 80909
Hisamitsu Investigator Site DeLand Florida 32720
Hisamitsu Investigator Site Hallandale Florida 33009
Hisamitsu Investigator Site Ocala Florida 34474
Hisamitsu Investigator Site Ormond Beach Florida 32174
Hisamitsu Investigator Site Austell Georgia 30106
Hisamitsu Investigator Site Savannah Georgia 31405
Hisamitsu Investigator Site Stockbridge Georgia 30281
Hisamitsu Investigator Site Chicago Illinois 60616
Hisamitsu Investigator Site Madisonville Kentucky 42431
Hisamitsu Investigator Site Baton Rouge Louisiana 70809
Hisamitsu Investigator Site Lake Charles Louisiana 70601
Hisamitsu Investigator Site Flint Michigan 48504
Hisamitsu Investigator Site Omaha Nebraska 68114
Hisamitsu Investigator Site Berlin New Jersey 08009
Hisamitsu Investigator Site Raleigh North Carolina 27612
Hisamitsu Investigator Site Cincinnati Ohio 45206
Hisamitsu Investigator Site Zanesville Ohio 43701
Hisamitsu Investigator Site Oklahoma City Oklahoma 73112
Hisamitsu Investigator Site Duncansville Pennsylvania 16635
Hisamitsu Investigator Site Houston Texas 77074
Hisamitsu Investigator Site Salt Lake City Utah 84108

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00647231, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 3, 2015 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00647231 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →